Meskacel™ HPMC K4M

Meskacel™ HPMC E4 powder is a low-viscosity hydroxypropyl methyl cellulose semi-synthesised from natural plant cellulose. Its structure contains methoxy and hydroxypropyl groups, and presents different characteristics due to the differences in the content of substituents. It is stable in nat...

Meskacel™ HPMC E6 powder (hydroxypropyl methyl cellulose) is a nonionic cellulose mixed ether, prepared from natural cotton fibres or wood pulp through a series of precise chemical treatments. The exquisite combination of methoxy and hydroxypropoxy groups in its chemical structure endows it ...

Medical-grade Meskacel™ HPMC E15 powder is a low-viscosity hydroxypropyl methyl cellulose designed to meet various pharmaceutical excipient requirements. It is a white to slightly yellow fibrous or granular powder with a rich application history in the medical field. 

Meskacel™HPMC E50 powder (hydroxypropyl methyl cellulose) is a low-viscosity biocompatible medical excipient that can form a dense gel barrier to achieve long-acting drug sustained release (such as postoperative analgesic gel release time ≥72 hours). It is characterised by high purity, high perfo...

Medical-grade Meskacel™ HPMC E4M powder (hydroxypropyl methylcellulose) is a nonionic cellulose ether. When HPMC E4M is used as a pharmaceutical excipient, it regulates drug release through a synergistic mechanism of swelling-diffusion (Fickian diffusion) and dissolution-diffusion (non-Fickian diffusi...

Medical-grade Meskacel™ HPMC K100 powder (hydroxypropyl methylcellulose) features low viscosity, high drug loading compatibility and excellent biocompatibility. Viscosity range (100±20 mPa·s, 2% aqueous solution at 20℃), suitable for drug-controlled release, skin barrier repair and mucosal d...

Pharmaceutical-grade HPMC K15M powder is a nonionic cellulose ether, chemically modified from natural cellulose, and has excellent water solubility and adhesion. Its nominal viscosity is 15,000 mPa · s (2% aqueous solution, 20℃).

Meskacel™ L-HPC LP11 powder (low-substituted hydroxypropyl cellulose) achieves efficient disintegration through capillary permeation and hydrogen bond breaking mechanism based on its low degree of substitution (≤11%) and porous microcrystalline structure. Its high porosity (≥60%) enables it ...

Meskacel™ L-HPC LP22 power (Low-substituted hydroxypropyl cellulose LP22) is a high-performance pharmaceutical excipient. Its unique physicochemical properties make it a core disintegrant and filler for tablets, capsules, and sustained-release preparations. It is suitable for wet granulation, dry gran...

Meska Joinway's pharmaceutical-grade hydroxypropyl cellulose (HPC) is a high-purity, non-ionic, water-soluble cellulose ether derived from chemically modified natural cellulose. It exhibits excellent solubility in water and various polar organic solvents and offers multiple functional proper...

Meskacel™ HPMC E5 powder (hydroxypropyl methylcellulose) is a nonionic cellulose ether, specially designed for rapid release preparations. Its core advantages include:
Low viscosity (5-10 mPa·s for 2% solution): Good fluidity, suitable for direct tablet pressing and wet granulation.
Rapid solubility:...

The viscosity of Meskacel™ HPMC K100M powder 5% aqueous solution reaches 100,000±10% cps (at 20℃, Brookfield method). After absorbing water, it rapidly expands to form a dense hydrated gel layer, significantly delaying drug release. It is suitable for medical-grade 24-hour long-acting s...

Meska Joinwray Pharmaceutical Co., Ltd. has been a trusted manufacturer ofpharmaceutical excipients since its establishment in 2003,operating in fullcompliance with Good Manufacturing Practice (GMP') standards.wespecialize in praviding a comprehensive portfolio of cellulose ethers andhigh-performance excipients designed to optimize formulationdevelopment, imprave solubility, and enhance the delivery of activepharmaceutical ingredients.Since 2003,Meska Joinway has built a strong global presence, servingcustomers across multiple countries and fostering long-term,reliablepartnerships in the pharmaceutical industry.

Meska Joinway Pharmaceutical Co., Ltd., established in 2003, specializes in the production and operation of a variety of new pharmaceutical-grade and industrial-grade cellulose ethers. Its pharmaceutical-grade cellulose related products are technologically leading in China. They are widely used in plant hollow capsules, film coating powders and related film-forming agents, sustained-release and controlled-release dosage form matrix materials, solid dosage form binders, stabilizers for ointments and emulsifiable concentrates, and thickening agents for lotions and gels.

 

Meska Joinway is a high-tech enterprise with over 20 years of experience in the production and sales of new pharmaceutical excipients and various industrial cellulose ethers. It is located in the provincial chemical industrial park of Linghu Town, Nanxun District, Huzhou City, China. The total investment in the construction of the factory area is $ 187 million, with a land area of approximately 94,000 square meters and an annual production capacity of 38,000 tons of cellulose ethers. The company has established a talent-driven pattern centered on innovation and R&D, with the proportion of professional and technical personnel dedicated to new product R&D exceeding 20%. Currently, research and development bases for new types of pharmaceutical excipients, pharmaceutical intermediates, preparations, and various industrial cellulose ethers have been established.